Myrbetriq Receives FDA Approval

by Kathy Jones on  June 29, 2012 at 10:55 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

The US Food and Drug Administration has confirmed that it has approved Japanese drug maker Astellas Pharma's Myrbetriq pill for treating overactive bladder in adults.
 Myrbetriq Receives FDA Approval
Myrbetriq Receives FDA Approval

The approval was along the expected lines after an advisory committee voted that the drug's benefits in treating overactive bladder outweighed the risk of side effects which includes heart and liver problems. The decision came following results of clinical trials which showed that 50-milligram dose of the drug reduced the number of trips to the bathroom by four times over a period of 7 days when compared to placebo.

Stating that overactive bladder was an uncomfortable and potentially serious condition, Dr Victoria Kusiak, deputy director in an FDA office for drug evaluation, said, "An estimated 33 million Americans suffer from overactive bladder, which is uncomfortable, disrupting, and potentially serious. Today's approval provides a new treatment option for patients with this debilitating condition."



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...